ClinicalTrials.gg
RecruitingNCT06341868Updated Jan 2, 2026

Dynamic Muscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction in Military Academy Cadets

An interventional study of KneeStim in Anterior Cruciate Ligament Injuries, sponsored by Keller Army Community Hospital. Recruiting at 1 site in United States. Open to participants aged 17 Years to 27 Years. Per ClinicalTrials.gov, last updated 2026-01-02.

Sponsored by Keller Army Community Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
17 Years to 27 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 176 studies in Anterior Cruciate Ligament Injuries with a site in United States — 44 open to participants now, 62 under way, 3 of them phase 3. Anterior Cruciate Ligament Injuries · United States.

Planned enrollment
57th of 152
60 · median 50
Started
2024
with 14 others
No phase
113 of 176
27 open now
Primary completion
2026-09
later than 17 of 61 live
Registered
149th of 176
by date

Among the 176 studies in Anterior Cruciate Ligament Injuries with a site in United States, this one is the 57th largest by planned enrollment of the 152 interventional ones that give a count, is one of 15 that started in 2024, is one of 113 with no phase, reaches primary completion later than 17 of the 61 other live ones, and was the 149th registered.

Anterior Cruciate Ligament Injuries

627 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

44 of the 176 studies in Anterior Cruciate Ligament Injuries with a site in United States are open now. Recruiting first, the newest first:

38 more — sign in →

All 44 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 17 Years to 27 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 176 studies in Anterior Cruciate Ligament Injuries with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to examine the effects of 12 weeks of post-operative use of a novel wearable electrical stimulation knee sleeve device (KneeStim) on post-operative biomechanical function (gait). Participants will be United States Military Academy cadets aged 17-27 years. The main questions it aims to answer are:

  • Examine the effects of KneeStim wear on cadets' post-operative gait
  • Examine changes in site-specific skeletal muscle mass
  • Examine the changes in patient-reported outcomes
  • Assess time to return to full duty
  • Compare Bioelectrical Impedance Analysis (BIA) measurements to Magnetic Resonance Imaging (MRI) measurements (total thigh volume)
  • Determine the concurrent criterion validity of the KneeStim device compared to gold- standard metrics (3D Motion Capture)

Participants will undergo body composition analysis, MRI, strength testing, standard of care rehabilitation, gait analysis, and complete surveys. Participants will wear the KneeStim during their standard of care rehabilitation visits for the first 5 weeks post-operative, and throughout daily tasks from 6-12 weeks.

Researchers will compare a control group (standard of care + KneeStim controlled low intensity) to an experimental group (standard of care + KneeStim flexible intensity) to assess the aims previously mentioned..

Read the detailed description

Anterior cruciate ligament (ACL) tears have a recovery time of nearly 6-12 months with operative treatment. While most service members return to full duty after ACL reconstruction, it is delayed by quadriceps activation, muscle weakness, and abnormal gait patterns. Neuromuscular electric stimulation devices are already being used in physical therapy to complement gains in muscle strength and size. The innovation of KneeStim, is that it can be used to stimulate knee muscles while the individual is engaging in their daily activities. This study looks at the effects of 12 weeks of post-operative use of the KneeStim on biomechanical function (gait) in United States Military Academy Cadets aged 17-27 years of age. The investigators hypothesize that using the KneeStim will accelerate normalization of the biomechanical function parameters of gait and thus return to full duty.

03

Conditions studied

  • Anterior Cruciate Ligament Injuries

Keywords

  • knee
  • Anterior Cruciate Ligament
  • Gait
  • Neuromuscular electric stimulation
04

Who can participate

Ages eligible
17 Years to 27 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. United States Military Academy cadet between ages of 17-27 years
  2. Undergoing a Primary ACL Reconstruction, or Revision ACL Reconstruction

Exclusion criteria

Exclusion Criteria:

  1. Concomitant or prior high tibial osteotomy (HTO)
  2. Concomitant or prior cartilage restoration procedure
  3. Concomitant ligamentous reconstruction (lateral collateral ligament; posterior cruciate ligament; medial collateral ligament)
  4. to using the KneeStim device

    - Use of pacemaker, defibrillators, or other implanted electronic devices, as this may cause electric shock, burns, electrical interference, or death Unstable angina or decompensated heart failure Epilepsy or history of seizure disorder Pregnancy or planning to become pregnant (Self reported) Critical ischemia of lower limbs Moderate to severe dementia Altered sensation at the knee such that the user cannot feel a pinprick Undiagnosed pain syndromes

  5. Any meniscus tear precluding weight bearing for 6 weeks.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Sham comparator
    Standard of Care + KneeStim controlled low intensity

    Low intensity range

    Device: KneeStim

  • Experimental
    Standard of Care + KneeStim flexible intensity

    Flexible to high intensity range

    Device: KneeStim

Interventions

  • DeviceKneeStim

    Participant will be randomized to either be in control or experimental group

06

What researchers measure

Primary outcomes

  1. Change in gait post-operatively assessed by the KneeStimTM Device

    Effects of a novel wearable electrical stimulation knee sleeve device (KneeStim) on post-operative biomechanical function (femur sagittal angle, tibial sagittal angle, femur coronal angle, tibial coronal angle, femur and tibia coronal velocity)

    Time frame: 6 weeks;3, 6, 9, 12 months post-operative

Secondary outcomes

  1. change in gait post-operatively assessed by 3D Motion capture

    Kinetic and kinematic biomechanical data will be monitored throughout the return to run phases of rehabilitation in knee and hip joints (walking and running); changes in gait speed (walking and running); changes in join angle range of motion (walking and running); changes in stride length (walking and running)

    Time frame: 3, 6, 9, 12 months post-operative

  2. change in gait post-operatively assessed by force plate instrumented treadmill

    Ground reaction forces will be recorded simultaneously with the motion capture system via force plates on an instrumented treadmill to determine force output between limbs during walking and running trials.

    Time frame: 3, 6, 9, 12 months post-operative

  3. change in muscle volume assessed by MRI

    Summation of the cross-sectional area and volumetric measurements

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  4. ACL graft healing assessed by MRI

    Signal intensity will be used to monitor tissue quality throughout healing process

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  5. Change in isometric muscle strength assessed by CSMi HUMAC NORM

    Rate of torque development (in ms) over time.

    Time frame: 3, 6, 9, 12 months post-operative

  6. Change in skeletal muscle mass assessed by bioelectrical impedance analysis (SECA BIA)

    Skeletal muscle mass will be measured (in kg) to monitor rate of muscle hypertrophy/atrophy over rehabilitation timeline.

    Time frame: pre-operative, 4, 8 weeks; 3, 6, 9, 12 months post-operative

  7. Change in lean body mass assessed by bioelectrical impedance analysis (SECA BIA)

    Muscle mass, bone mass, and body fluid (kg/m2) will be measured to contribute to Body Mass Index (BMI) scores.

    Time frame: pre-operative, 4, 8 weeks; 3, 6, 9, 12 months post-operative

  8. Change in fat mass assessed by bioelectrical impedance analysis (SECA BIA)

    Fat mass (kg/m2) will be measured to contribute to body mass index (BMI) scores.

    Time frame: pre-operative, 4, 8 weeks; 3, 6, 9, 12 months post-operative

  9. Change in knee pain and function assessed by the Knee Injury and Osteoarthritis Score (KOOS)

    The KOOS is a self-reported outcome measure assessing the patient's perspective about the health, symptoms, and functionality of their knee. It is a 42-item questionnaire, including 5 subscales: symptoms, pain, activities of daily living, function in sports/recreation, and quality of life. A likert scale is used and all items have five possible answers ranging from 0 (no problems) to 4 (extreme problems). The five subscale scores are calculated as the sum of the items for each subscale. Scores are then transformed to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no knee problems.

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  10. Change in knee pain and function assessed by the International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC)

    The IKDC is a self-reported outcome measure that assesses knee disability and function before and after treatment. It consists of 18 items that measure symptoms, function, and sports activity. Response types include 5-point Likert Scales, 11-point Likert scales, and dichotomous "yes-no" responses.

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  11. Change in knee pain assessed by the Patient-Reported Outcome Measure Information System (PROMIS-29)

    PROMIS-29 is a self-reported outcome measure assessing for the patient's pain intensity. It is a 28-item questionnaire, which includes 7 subscales of four items each: physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance. A likert scale is used for all domain response scales, however they vary in responses.

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  12. Change in knee function assessed with the Single Assessment Numeric Evaluation Method (SANE)

    Participants will provide a numerical rating from 0 (least normal) to 100 (most normal) of the perceived improvement in knee health in relation to their pre-injury baseline.

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  13. Change in knee function assessed by the Marx Activity Rating Scale (MARS)

    MARS includes 4 items that assess the frequency of running, cutting, decelerating, and pivoting based on the subjects "healthiest and most active state in the past year". Each item is scored on a 5-point ordinal scale ranging from 0 (less than 1 time in a month) to 4 (4 or more times in a week), and the total scale score is obtained by summing the individual items' scores (range, 0-16). A higher score indicates more functional demand on the knee joint and potentially a higher risk of injury.

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  14. Impact of ACL surgery on overall quality of life assessed by the Anterior Cruciate Ligament-Quality of Life (ACL-QOL)

    The questionnaire consists of 32 equally weighted questions that are answered using a 100 mm visual analog scale and is scored of 100. It comprises 5 domains, including (1) symptoms and physical complaints (5 items); (2) work-related concerns (4 items); (3) recreational activity and sport participation or competition (12 items); (4) lifestyle (6 items); and (5) social and emotional (5 items).

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  15. Change of running gait function from the patients' perspective assessed by the University of Wisconsin Running Injury and Recovery Index (UWRI)

    The 9-item UWRI assesses running ability following a running related injury, with the maximum score of 36 indicating a return to preinjury running ability.

    Time frame: pre-operative, 3, 6, 9, 12 months post-operative

  16. Change of knee pain from the patients' perspective assessed by the Visual Analog Scale (VAS)

    Will measure average knee pain over a given timeframe from 0 to 10 cm visual analogue scale where 0 cm equals no pain and 10 cm indicates the most severe pain the patient could imagine. Higher numbers equal greater levels of reported pain.

    Time frame: Weekly from 1-week post-operative until 3 months; monthly from 4-12 months

  17. Time to return to full duty

    Measured by the time from post-operative timepoint to time of full clearance for military tasks

    Time frame: 12 months post-operative

  18. Difference between the Tindeq Progessor and CSMi HUMAC NORM in measuring peak isometric knee extensor torque.

    Peak isometric extensor torque (nm/kg).

    Time frame: At either month 3, 6, 9, or 12, Tindeq testing will occur 24-72 hours after the bilateral strength assessment using the CSMi HUMAC NORM.

  19. Difference between the Tindeq Progessor and CSMi HUMAC NORM in measuring knee extensor rate of torque development.

    Rate of torque development (nm/s)

    Time frame: At either month 3, 6, 9, or 12, Tindeq testing will occur 24-72 hours after the bilateral strength assessment using the CSMi HUMAC NORM.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003 Nov 3;1:64. doi: 10.1186/1477-7525-1-64. PubMed 14613558 ↗
  • Jacobson RP, Kang D, Houck J. Can Patient-Reported Outcomes Measurement Information System(R) (PROMIS) measures accurately enhance understanding of acceptable symptoms and functioning in primary care? J Patient Rep Outcomes. 2020 May 20;4(1):39. doi: 10.1186/s41687-020-00206-9. PubMed 32436001 ↗
  • O'Connor CM, Ring D. Correlation of Single Assessment Numeric Evaluation (SANE) with other Patient Reported Outcome Measures (PROMs). Arch Bone Jt Surg. 2019 Jul;7(4):303-306. PubMed 31448305 ↗
  • Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, Harris JD. Validation of Digital Visual Analog Scale Pain Scoring With a Traditional Paper-based Visual Analog Scale in Adults. J Am Acad Orthop Surg Glob Res Rev. 2018 Mar 23;2(3):e088. doi: 10.5435/JAAOSGlobal-D-17-00088. eCollection 2018 Mar. PubMed 30211382 ↗
  • Marx RG, Stump TJ, Jones EC, Wickiewicz TL, Warren RF. Development and evaluation of an activity rating scale for disorders of the knee. Am J Sports Med. 2001 Mar-Apr;29(2):213-8. doi: 10.1177/03635465010290021601. PubMed 11292048 ↗
  • Winterstein AP, McGuine TA, Carr KE, Hetzel SJ. Comparison of IKDC and SANE Outcome Measures Following Knee Injury in Active Female Patients. Sports Health. 2013 Nov;5(6):523-9. doi: 10.1177/1941738113499300. PubMed 24427427 ↗
  • Cobian DG, Koch CM, Amendola A, Williams GN. Knee Extensor Rate of Torque Development Before and After Arthroscopic Partial Meniscectomy, With Analysis of Neuromuscular Mechanisms. J Orthop Sports Phys Ther. 2017 Dec;47(12):945-956. doi: 10.2519/jospt.2017.7310. Epub 2017 Oct 9. PubMed 28992769 ↗
  • Kline PW, Morgan KD, Johnson DL, Ireland ML, Noehren B. Impaired Quadriceps Rate of Torque Development and Knee Mechanics After Anterior Cruciate Ligament Reconstruction With Patellar Tendon Autograft. Am J Sports Med. 2015 Oct;43(10):2553-8. doi: 10.1177/0363546515595834. Epub 2015 Aug 14. PubMed 26276828 ↗
  • Higgins LD, Taylor MK, Park D, Ghodadra N, Marchant M, Pietrobon R, Cook C; International Knee Documentation Committee. Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form. Joint Bone Spine. 2007 Dec;74(6):594-9. doi: 10.1016/j.jbspin.2007.01.036. Epub 2007 Aug 6. PubMed 17888709 ↗
  • Hill OT, Bulathsinhala L, Scofield DE, Haley TF, Bernasek TL. Risk factors for soft tissue knee injuries in active duty U.S. Army soldiers, 2000-2005. Mil Med. 2013 Jun;178(6):676-82. doi: 10.7205/MILMED-D-13-00049. PubMed 23756076 ↗
  • Lepley LK, Davi SM, Burland JP, Lepley AS. Muscle Atrophy After ACL Injury: Implications for Clinical Practice. Sports Health. 2020 Nov/Dec;12(6):579-586. doi: 10.1177/1941738120944256. Epub 2020 Aug 31. PubMed 32866081 ↗
  • Aguero AD, Irrgang JJ, MacGregor AJ, Rothenberger SD, Hart JM, Fraser JJ. Sex, military occupation and rank are associated with risk of anterior cruciate ligament injury in tactical-athletes. BMJ Mil Health. 2023 Nov 22;169(6):535-541. doi: 10.1136/bmjmilitary-2021-002059. PubMed 35165197 ↗
  • Hauret KG, Jones BH, Bullock SH, Canham-Chervak M, Canada S. Musculoskeletal injuries description of an under-recognized injury problem among military personnel. Am J Prev Med. 2010 Jan;38(1 Suppl):S61-70. doi: 10.1016/j.amepre.2009.10.021. PubMed 20117601 ↗
  • Molloy JM, Pendergrass TL, Lee IE, Hauret KG, Chervak MC, Rhon DI. Musculoskeletal Injuries and United States Army Readiness. Part II: Management Challenges and Risk Mitigation Initiatives. Mil Med. 2020 Sep 18;185(9-10):e1472-e1480. doi: 10.1093/milmed/usaa028. PubMed 32107561 ↗
  • Levine M, McElroy K, Stakich V, Cicco J. Comparing conventional physical therapy rehabilitation with neuromuscular electrical stimulation after TKA. Orthopedics. 2013 Mar;36(3):e319-24. doi: 10.3928/01477447-20130222-20. PubMed 23464951 ↗

Individual participant data

Plan to share: Yes — all individual participant data (IPD) that underlie results in a publication.

Supporting information: Study protocol, Statistical analysis plan

Time frame: starting 6 months after publication

Access criteria: request can be made to study contacts and will be reviewed by the study principal investigator and human research protections office.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Sep 2026, 24 months after the start.

Of 279 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 24 months is below that.

Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2024
First posted
Apr 2, 2024
StartActual
Sep 19, 2024
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
Jan 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06341868
Lead sponsor
Keller Army Community Hospital
Collaborators
Medical Technology Enterprise Consortium
Responsible party
Shawn Gee, MD (MD, Keller Army Community Hospital) — Principal investigator
First posted
Apr 2, 2024
Start date
Sep 19, 2024
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Jan 2, 2026

Study contacts

Natalia B Prando, MA
Contact
natalia.b.prando.ctr@health.mil
315-774-8368
Madison Mach, PhD
Contact
madison.s.mach.ctr@health.mil
315-774-8368
Shawn M Gee, MD
principal investigator · Keller Army Community Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion